The discovery of the mitogen activated protein kinase (MAPK) cascade and its antagonism by PP2A, and that the oncogenic SV40 small T antigen was a PP2A inhibitor [54,55], led to the assumption that OA and MC tumor promotion was mediated mainly by stimulation of MAPK to enhance cell proliferation and survival. The gene discussed is PTPA; the disease is neoplasm.